These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 19889623)
1. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait. Dimitrov T; Dashti AA; Albaksami O; Jadaon MM J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955 [TBL] [Abstract][Full Text] [Related]
3. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003. Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897 [TBL] [Abstract][Full Text] [Related]
4. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi. Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513 [TBL] [Abstract][Full Text] [Related]
5. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. Turner AK; Nair S; Wain J J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934 [TBL] [Abstract][Full Text] [Related]
6. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A. Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030 [TBL] [Abstract][Full Text] [Related]
7. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003. Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318 [TBL] [Abstract][Full Text] [Related]
8. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia. Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657 [TBL] [Abstract][Full Text] [Related]
9. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region? Capoor MR; Nair D; Walia NS; Routela RS; Grover SS; Deb M; Aggarwal P; Pillai PK; Bifani PJ Epidemiol Infect; 2009 Jun; 137(6):871-8. PubMed ID: 18687156 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin. Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918 [TBL] [Abstract][Full Text] [Related]
12. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia. Yanagi D; de Vries GC; Rahardjo D; Alimsardjono L; Wasito EB; De I; Kinoshita S; Hayashi Y; Hotta H; Osawa R; Kawabata M; Shirakawa T Diagn Microbiol Infect Dis; 2009 Aug; 64(4):422-6. PubMed ID: 19631095 [TBL] [Abstract][Full Text] [Related]
13. High-resolution melting assay for the detection of gyrA mutations causing quinolone resistance in Salmonella enterica serovars Typhi and Paratyphi. Slinger R; Bellfoy D; Desjardins M; Chan F Diagn Microbiol Infect Dis; 2007 Apr; 57(4):455-8. PubMed ID: 17156963 [TBL] [Abstract][Full Text] [Related]
14. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates]. Guo Y; Pei X; Liu X Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489 [TBL] [Abstract][Full Text] [Related]
15. LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica serotypes Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin. Walker RA; Skinner JA; Ward LR; Threlfall EJ Int J Antimicrob Agents; 2003 Dec; 22(6):622-5. PubMed ID: 14659662 [TBL] [Abstract][Full Text] [Related]
16. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A. Song Y; Roumagnac P; Weill FX; Wain J; Dolecek C; Mazzoni CJ; Holt KE; Achtman M J Antimicrob Chemother; 2010 Aug; 65(8):1631-41. PubMed ID: 20511368 [TBL] [Abstract][Full Text] [Related]
17. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Nath G; Maurya P Int J Antimicrob Agents; 2010 May; 35(5):482-5. PubMed ID: 20188522 [TBL] [Abstract][Full Text] [Related]
18. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan. Lee CJ; Su LH; Huang YC; Chiu CH J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712 [TBL] [Abstract][Full Text] [Related]
20. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones]. Lei YC; Wang HB; Sun ZY; Shen ZY Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]